CK Life Sciences International Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Employees
  • 1,932

Employees

  • Stock Symbol
  • 00775

Stock Symbol

  • Investments
  • 17

  • Share Price
  • $0.05
  • (As of Friday Closing)

CK Life Sciences International General Information

Description

CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The operating segments of the company are Agriculture-related and Health. The company derives maximum revenue from the health segment. The overall product portfolio of the company involves a presence that spans North America and the Asia Pacific.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
HKG
Corporate Office
  • 2 Dai Fu Street
  • Tai Po Industrial Estate
  • Hong Kong
  • Hong Kong
+852 2126 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CK Life Sciences International Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.05 $0.05 $0.04 - $0.10 $437M 9.6B 7.12M

CK Life Sciences International Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 1,455,726 1,455,726 1,650,657 1,618,484
Revenue 679,856 679,856 673,683 695,018
EBITDA 78,114 78,114 75,737 74,814
Net Income 2,203 2,203 16,851 20,945
Total Assets 1,439,337 1,439,337 1,441,961 1,504,351
Total Debt 759,007 759,007 761,012 796,737
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CK Life Sciences International Executive Team (4)

Name Title Board Seat Contact Info
Ying Choi Yu Chief Executive Officer & Board Member
Kam Lam President
Tak Chuen Ip Board Member & Executive
You’re viewing 3 of 4 executive team members. Get the full list »

CK Life Sciences International Board Members (7)

Name Representing Role Since
000 000 0000 Self Board Member 000 0000
0000 00000 Self Board Member 000 0000
000 00000 00 CK Life Sciences International Board Member & Executive 000 0000
0000 0000 00 CK Life Sciences International Chief Executive Officer & Board Member 000 0000
You’re viewing 4 of 7 board members. Get the full list »

CK Life Sciences International Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CK Life Sciences International Investments & Acquisitions (17)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Pharus Diagnostics 25-Jul-2022 00000 0000 0000 Diagnostic Equipment
Nangiloc Colignan Farm (Farm Assets) 01-Dec-2018 000000000 Buildings and Property
Polynoma 16-Nov-2017 0000000000 Biotechnology
Optigen Ingredients 01-Jan-2014 0000000000 Specialty Chemicals
Cheetham Salt 29-Nov-2012 Merger/Acquisition 00000 Food Products 000 000
You’re viewing 5 of 17 investments and acquisitions. Get the full list »

CK Life Sciences International Subsidiaries (4)

Company Name Industry Location Founded
Polynoma Biotechnology San Diego, CA 2007
Lipa Pharmaceuticals Pharmaceuticals Minto, Australia 0000
WEX Pharmaceuticals Drug Delivery Vancouver, Canada 0000
Cheetham Salt Food Products Melbourne, Australia 0000
To view CK Life Sciences International’s complete subsidiaries history, request access »

CK Life Sciences International ESG

Risk Overview

Risk Rating

Updated October, 01, 2023

23.17 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,191

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 921

Rank

00.00

Percentile

Biotechnology

Subindustry

00 of 405

Rank

00.00

Percentile

To view CK Life Sciences International’s complete esg history, request access »

CK Life Sciences International Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Optigen Ingredients 01-Jan-2014 000000000000000000 Completed
  • 00 0000 00000000 0
To view CK Life Sciences International’s complete exits history, request access »

CK Life Sciences International FAQs

  • When was CK Life Sciences International founded?

    CK Life Sciences International was founded in 2000.

  • Who is the CEO of CK Life Sciences International?

    Ying Choi Yu is the CEO of CK Life Sciences International.

  • Where is CK Life Sciences International headquartered?

    CK Life Sciences International is headquartered in Hong Kong, Hong Kong.

  • What is the size of CK Life Sciences International?

    CK Life Sciences International has 1,932 total employees.

  • What industry is CK Life Sciences International in?

    CK Life Sciences International’s primary industry is Biotechnology.

  • Is CK Life Sciences International a private or public company?

    CK Life Sciences International is a Public company.

  • What is CK Life Sciences International’s stock symbol?

    The ticker symbol for CK Life Sciences International is 00775.

  • What is the current stock price of CK Life Sciences International?

    As of 14-Jun-2024 the stock price of CK Life Sciences International is $0.05.

  • What is the current market cap of CK Life Sciences International?

    The current market capitalization of CK Life Sciences International is $437M.

  • What is CK Life Sciences International’s current revenue?

    The trailing twelve month revenue for CK Life Sciences International is $680M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »